ImmuPharma plc Share Price
Stocks
IMM
GB0033711010
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
London S.E.
10:59:05 11/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 3.100 GBX | -0.96% |
|
-4.76% | -50.00% |
| 10-29 | WINNERS & LOSERS: Vanquis plunges on outlook cut, Blue Star jumps | AN |
| 10-16 | WINNERS & LOSERS: Iofina falls as output weaker than expected | AN |
| Market Cap | 19.57M 26.07M 23.38M 21.55M 37.04M 2.44B 38.07M 258M 103M 1.31B 97.86M 95.78M 4.14B | P/E 2024 |
-2.01x | P/E 2025 | -16.8x |
|---|---|---|---|---|---|
| Enterprise Value | 18.22M 24.27M 21.77M 20.06M 34.48M 2.28B 35.44M 240M 95.7M 1.22B 91.09M 89.16M 3.85B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
95.04% | Yield 2024 * |
-
| Yield 2025 | - |
London S.E.GBX
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| IMM | Delayed | |
CBOE
| IMM | Real-time | |
|
Deutsche Boerse AG
| 25I | Delayed | |
|
Börse Stuttgart
| 25I | Delayed | |
|
Boerse Muenchen
| 25I | Real-time |
Last Transcript: ImmuPharma plc
| 1 day | -0.96% | ||
| 1 week | -4.76% | ||
| Current month | -4.62% | ||
| 1 month | -24.39% | ||
| 3 months | -16.22% | ||
| 6 months | -27.40% | ||
| Current year | -50.00% |
| 1 week | 3 |  | 4 |
| 1 month | 3 | | 4.9 |
| Current year | 3 | | 11 |
| 1 year | 3 | | 11.5 |
| 3 years | 0.82 | | 19.4 |
| 5 years | 0.82 | | 19.4 |
| 10 years | 0.82 | | 193.74 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 70 | 29/07/2021 | |
Ashley Clarke
DFI | Director of Finance/CFO | - | 02/12/2024 |
| Chief Tech/Sci/R&D Officer | - | 31/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Lisa Baderoon
BRD | Director/Board Member | 60 | 28/07/2021 |
| Chairman | 70 | 29/09/2015 | |
Timothy Franklin
BRD | Director/Board Member | 62 | 15/07/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 19/04/24 | Free | Director | 3,000,000 | 0.7204% | ||
| 19/04/24 | Free | Director | 2,000,000 | 0.4803% | ||
| 22/12/22 | Free | Chief Operating Officer | 1,575,000 | 0.4724% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.96% | -4.76% | -66.52% | +81.61% | 26.07M | |
| +0.01% | +11.10% | +60.83% | +70.43% | 68.32B | |
| +0.67% | +6.72% | +14.06% | +89.05% | 60.26B | |
| +0.03% | -0.03% | +19.65% | +97.08% | 55.86B | |
| +1.60% | +19.44% | +28.80% | +112.95% | 48.43B | |
| -1.32% | +4.78% | +29.15% | +40.40% | 45.34B | |
| -3.54% | -0.60% | +207.76% | +879.50% | 41.76B | |
| -3.33% | +6.90% | +22.78% | +48.07% | 34.5B | |
| -1.35% | -1.34% | +83.95% | +56.33% | 33.8B | |
| -1.49% | +1.16% | +47.05% | +0.16% | 25.96B | |
| Average | -0.97% | +3.75% | +44.75% | +147.56% | 41B | |
| Weighted average by Cap. | -0.69% | +5.25% | +53.92% | +152.55% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -2.48M -3.31M -2.97M -2.73M -4.7M -310M -4.83M -32.74M -13.05M -166M -12.42M -12.15M -525M | -1.81M -2.41M -2.16M -1.99M -3.42M -226M -3.52M -23.83M -9.5M -121M -9.04M -8.85M -382M |
| Net Debt | -237K -316K -283K -261K -448K -29.59M -461K -3.12M -1.24M -15.85M -1.18M -1.16M -50.12M | -1.35M -1.8M -1.62M -1.49M -2.56M -169M -2.63M -17.83M -7.1M -90.5M -6.76M -6.62M -286M |
Employees
7
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/11/26 | GBX 3.100 | -0.96% | 287,678 |
| 10/11/26 | GBX 3.130 | -3.25% | 1,123,498 |
| 09/11/26 | GBX 3.235 | -1.67% | 3,688,418 |
| 06/11/26 | GBX 3.290 | +9.48% | 8,551,748 |
| 05/11/26 | GBX 3.005 | -7.68% | 2,393,639 |
- Stock Market
- Stocks
- IMM Stock
Select your edition
All financial news and data tailored to specific country editions
